|
1
|
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.
|
Kidney Int
|
2006
|
2.22
|
|
2
|
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.
|
Diabetologia
|
2006
|
1.42
|
|
3
|
Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity.
|
J Immunol
|
1998
|
1.32
|
|
4
|
Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells.
|
Diabetologia
|
2007
|
0.99
|
|
5
|
Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo.
|
Immunology
|
1998
|
0.94
|
|
6
|
A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis.
|
Kidney Int
|
2007
|
0.92
|
|
7
|
Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.
|
Diabetologia
|
2010
|
0.92
|
|
8
|
Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice.
|
Diabetologia
|
2009
|
0.91
|
|
9
|
Interleukin-10 is a mesangial cell growth factor in vitro and in vivo.
|
Lab Invest
|
1997
|
0.90
|
|
10
|
Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.
|
Kidney Int
|
1997
|
0.89
|
|
11
|
Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice.
|
Diabetologia
|
2008
|
0.88
|
|
12
|
A novel method of microwave treatment for detection of cytoplasmic and nuclear antigens by flow cytometry.
|
J Immunol Methods
|
1996
|
0.88
|
|
13
|
De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis.
|
J Am Soc Nephrol
|
1996
|
0.87
|
|
14
|
CD44-mediated neutrophil apoptosis in the rat.
|
Kidney Int
|
2000
|
0.86
|
|
15
|
Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K/MAPK signalling.
|
Nephron Exp Nephrol
|
2012
|
0.83
|
|
16
|
Interleukin-1 in renal fibrosis.
|
Kidney Int Suppl
|
1996
|
0.81
|
|
17
|
Deoxyspergualin inhibits mesangial cell proliferation and major histocompatibility complex class II expression.
|
J Am Soc Nephrol
|
1995
|
0.79
|
|
18
|
CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice.
|
Endocrinology
|
2014
|
0.78
|
|
19
|
Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
|
Clin Exp Immunol
|
2000
|
0.76
|
|
20
|
Deoxyspergualin: a new immunosuppressive drug for the treatment of auto-immune disease.
|
Nephron
|
1995
|
0.75
|